i-Tracker Ustekinumab
Product Description
i-Tracker Ustekinumab is an automated assay intended for the quantitative measurement of Ustekinumab (anti-IL12/23) in human serum samples.
- Innovative CLIA technology
- Quantitative measurement of drug and anti-drug antibodies
- First results in less than 35 minutes; 60 results/hour
- Validated on princeps and biosimilars
- Controls and calibrators included
-
- Benson JM et al., Discovery and mechanism of Ustekinumab a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders, mAbs, 2011, 3:6, 535-545.
- Famenini S and al., The safety of ustekinumab in psoriasis, J. Drugs Dermatol., 2012, 11(8), 907-910.
- Papp KA et al., Long-term safety of Ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up, Br. J. Dermatol, 2013, 168(4):844-54.
- Feagan B.G. et al., Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease, N Engl J Med 2016;375:1946-60.
- Rutgeerts P et al., Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease, Gastroenterology, 2018, 155(4), 1045–1058.
- Soufflet N.et al., Concentrations of Ustekinumab during induction therapy associate with remission in patients with crohn’s disease. Clin Gastroenterol Hepatol 2019
Nov;17(12):2610-2612.
- Product Code: CTU 002-50
- Number of Tests: 50
- Sample Type: Serum
- Sample Volume: 25 µL
- Assay Range: 100 - 10 000 ng/mL
- Add to Enquiry Basket
Interested? Enquire now.
Add to Enquiry Basket
Related Products
| Assays | Certification | Platform | Clinical Area | Portfolio | RUO/IVD |
|---|---|---|---|---|---|
| i-Tracker anti-Ustekinumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker Infliximab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker Adalimumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker Certolizumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker Golimumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |
| i-Tracker Vedolizumab | CE Marked | i10iSYS | Therapeutic Drug Monitoring | TDM | IVD |